Clinical Scorecard: Treatment Considerations for Photobiomodulation for Retinal Disease
At a Glance
| Category | Detail |
|---|---|
| Condition | Retinal Diseases (specifically Age-Related Macular Degeneration and Diabetic Retinopathy) |
| Key Mechanisms | Photobiomodulation uses near-infrared and visible light to stimulate tissue repair by activating mitochondrial proteins, increasing ATP production, and reducing reactive oxygen species. |
| Target Population | Patients with early-to-intermediate nonexudative Age-Related Macular Degeneration (AMD). |
| Care Setting | Outpatient clinic setting. |
Key Highlights
- PBM has shown visual acuity benefits in patients with intermediate AMD.
- The LIGHTSITE III trial demonstrated significant improvements in best-corrected visual acuity (BCVA) in PBM-treated eyes.
- PBM is noninvasive and does not require pupillary dilation or topical anesthesia.
- Regular follow-up is essential to monitor treatment response and disease progression.
- PBM is not a replacement for established therapies such as antiVEGF treatment.
Guideline-Based Recommendations
Diagnosis
- Thorough pretreatment assessment to establish diagnosis of intermediate dry AMD.
- Utilize multimodal imaging including OCT, fundus photography, and fundus autofluorescence.
Management
- Administer PBM in a treatment course of 9 applications over 3 to 5 weeks, repeated 3 times per year.
Monitoring & Follow-up
- Conduct periodic ophthalmic examinations with BCVA and OCT imaging after every treatment cycle.
Risks
- Monitor for conversion to neovascularization as PBM does not replace antiVEGF treatments.
Patient & Prescribing Data
Patients with early-to-intermediate stages of retinal disease.
PBM is a disease-modifying intervention aimed at enhancing visual function and possibly slowing disease progression.
Clinical Best Practices
- Careful patient selection and adherence to established treatment protocols.
- Provide patient counseling to set reasonable expectations regarding treatment outcomes.
Related Resources & Content
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
